INTRODUCTION
Mammalian DNA methylation at 5-cytosine plays critical roles in many biological processes, including genomic imprinting, cellfate determination, chromatin architecture organization, and regulation of gene expression (Bird, 2002; Jaenisch and Bird, 2003; Smith and Meissner, 2013) . Genetic studies have revealed that DNA methylation is essential for mammalian development and adaptation to environmental signals (Jaenisch and Bird, 2003) . Abnormal DNA methylation has been observed in cancer and neurological disorders (Robertson, 2005) . Owing to the advancement in sequencing technologies, single-nucleotide resolution methylation maps for many types of human and mouse cells and tissues have been depicted (Lister et al., 2009 (Lister et al., , 2013 . Importantly, these maps have allowed for the identification of differentially methylated regions (DMRs) at base pair resolution during different stages of normal development as well as disease (De Jager et al., 2014; Landau et al., 2014) . However, investigation of the functional significance of these DMRs remains a challenge due to lack of appropriate molecular tools that enable efficient editing of DNA methylation in a targeted manner.
We set out to establish such a toolbox by hybridization of the key enzymes in the DNA methylation pathway with reprogrammable sequence-specific DNA-targeting molecular machinery. DNA methylation is established by two de novo DNA methyltransferases (Dnmt3a/b) and is maintained by Dnmt1 (Smith and Meissner, 2013) . Gene activation during development is associated with demethylation of promoter and enhancer sequences with the best-understood mechanism being passive demethylation by inhibition of Dnmt1. In addition, demethylation can be achieved through oxidation of the methyl group by TET (ten-eleven translocation) dioxygenases to form 5-hydroxymethylcytosine (5-hmC), and then restoration into unmodified cytosines by either DNA replication-dependent dilution or DNA glycosylase-initiated base excision repair (BER), a process termed as active demethylation and proposed to operate during specific developmental stages such as preimplantation embryos or in post-mitotic neurons (Wu and Zhang, 2014) .
Clustered regularly interspaced palindromic repeats (CRISPR), a type II bacterial adaptive immune system, has been modified to target the Cas9 nuclease to the desired genomic loci with sequence-specific guide RNAs for genome editing (Cong et al., 2013; Jinek et al., 2012; Mali et al., 2013) . Importantly, a catalytically inactive Cas9 (dCas9) was generated and engineered in several systems as a DNA targeting module to bring effector proteins such as transcriptional activator/suppressor, chromatin modifier, and green fluorescence protein to regulate gene expression, to modify chromatin, and to image genomic loci respectively (Chen et al., 2013; Gilbert et al., 2013; Hilton et al., 2015; Jinek et al., 2012; Konermann et al., 2015; Qi et al., 2013) .
In this study, we demonstrate that fusion of dCas9 with the Tet1 enzymatic domain or Dnmt3a allows for targeted erasure or establishment of DNA methylation, respectively. As a proof of principle, we first induced alterations to DNA methylation in two synthetic methylation reporters integrated in mouse embryonic stem cells (mESCs). We further show that targeted demethylation of BDNF promoter IV is sufficient to activate its expression in mouse cortical neurons, and that targeted (legend continued on next page) demethylation of a MyoD distal enhancer promotes reprogramming of fibroblasts into myoblasts and facilitates myotube formation. With dCas9-Dnmt3a, we demonstrate that targeted methylation at CTCF binding sites is able to block CTCF recruitment and to alter the expression of genes in the neighborhood loop by increasing their interaction frequencies with the superenhancers insulated in the targeted loops. Furthermore, lentiviral delivery of dCas9-Tet1 with target gRNAs into mice enabled in vivo activation of a methylation reporter by demethylation of its promoter. Thus, dCas9-Tet1 and dCas9-Dnmt3a provide powerful tools to investigate the functional significance of DNA methylation in a locus-specific manner.
RESULTS
A Modified CRISPR System to Edit DNA Methylation To achieve targeted editing of DNA methylation, we fused dCas9 with enzymes in the methylation/demethylation pathway (Figure 1A) . Based on previous studies using the TALE system to target specific CpGs (Bernstein et al., 2015; Maeder et al., 2013) , Tet1 and Dnmt3a were chosen as the effectors in our system. Co-expression of sequence-specific guide RNA (gRNA) would be expected to target dCas9-Tet1 or dCas9-Dnmt3a to the specific locus and mediate modification of DNA methylation status without altering the DNA sequence. To optimize this chimeric CRISPR/dCas9-effector system, we tested two types of dCas9-Tet1 lentiviral constructs with nuclear localization signal (NLS) at different positions: dCas9-NLS-Tet1 and NLSdCas9-NLS-Tet1 (Figures S1A and S1B). We also tested two types of gRNA lentiviral constructs, a widely used chimeric single-guide RNA referred to as gRNA (Jinek et al., 2012 ) and a modified guide RNA with enhanced capacity to guide Cas9 to the designed genomic locus referred to as E-gRNA (Chen et al., 2013) . Both gRNA constructs contain a puro selection cassette and a Cherry fluorescence protein cassette driven by an independent CMV promoter that allows for fluorescence activated cell sorting (FACS) of gRNA-expressing cells after lentiviral transduction ( Figure S1A ). Characterization of these constructs showed a robust gRNA-induced nuclear translocation for the dCas9-NLSTet1 construct (Figures S1C-S1E), and thus this construct was chosen for all experiments in order to minimize non-specific modifications of DNA. Two types of gRNA behaved similarly (Figures S1C-S1E) and thus were used interchangeably.
dCas9-Tet1 and dCas9-Dnmt3a Enable Targeted Alterations of CpG Methylation State
To assess whether the dCas9-Tet1 and -Dnmt3a fusion constructs would induce demethylation or de novo methylation, respectively, of specific sequences, we utilized a methylation reporter system previously developed in our laboratory (Stelzer et al., 2015) . This reporter system consists of a synthetic methylation-sensing promoter (conserved sequence elements from the promoter of an imprinted gene, Snrpn) that controls the expression of a GFP. Insertion of this reporter construct into a genomic locus was shown to faithfully report on the methylation state of the adjacent sequences (Stelzer et al., 2015) .
Demethylation of Specific CpGs
To test whether defined sequences could be demethylated, we introduced the dCas9-Tet1 construct in combination with gRNAs to target the Snrpn-GFP reporter inserted into the Dazl promoter ( Figure 1B ). Dazl is a germ cell specific gene, which is hypermethylated and not active in ES cells, and thus the GFP reporter is not expressed. To activate GFP expression by dCas9-Tet1, we designed four gRNAs targeting all 14 CpGs in the Snrpn promoter region ( Figure S2A ). After infection with lentiviral vectors co-expressing dCas9-Tet1 and the four gRNAs for 3 days, some infection-positive cells as labeled by Cherry positive signal expressed from gRNA construct began to turn on GFP ( Figure S2B ). To assess the activation efficiency by dCas9-Tet1 with target gRNAs, we analyzed the cells infected by both viruses using FACS. Among the Cherry positive population, about 26% of cells with target gRNAs activated GFP, whereas only 1% of cells with a scrambled gRNA were GFP positive ( Figures 1C and S2C ). These Cherry positive single cells were further cultured to allow for formation of ES cell colonies. Cells with target gRNAs, but not the scrambled gRNA, expressed GFP ( Figure 1D ). To confirm that the activation of GFP in these cells is caused by demethylation of the Snrpn promoter, we performed bisulfite sequencing of genomic DNA from these samples. As illustrated in Figures 1E and 1F, samples from cells with target gRNAs showed robust demethylation only in the Snrpn promoter region but not the adjacent Dazl locus, and samples from the cells with the scrambled gRNA showed a similar methylation status to the uninfected (mock) control. We further analyzed the GFP-positive and -negative populations within infected Cherry-positive cells. As shown in Figure S2D , a more robust demethylation of the Snrpn promoter region was observed in double-positive cells (Cherry + ;GFP + ). These results confirm the targeted erasure of DNA methylation by dCas9-Tet1 with gRNAs in proliferative cells.
De Novo Methylation of Specific CpGs
To assess whether a dCas9-Dnmt3a fusion protein could de novo methylate promoter sequences and silence gene expression, we used cells carrying the Snrpn-GFP reporter in the Gapdh promoter. These cells are GFP positive because Gapdh is unmethylated and expressed in ES cells (Stelzer et al., 2015) . We infected the Gapdh-Snrpn-GFP ESCs with lentiviruses expressing dCas9-Dnmt3a and gRNAs targeting the Snrpn promoter or a scrambled gRNA (Figures 2A and S2E) , followed by FACS analysis. Among infection-positive (Cherry-positive) population, about 12% of cells with target gRNAs inactivated GFP, whereas only 2% of cells with the scrambled gRNA were GFP negative (Figures 2B and S2F) . When the Cherry positive cells were grown in culture, (D) Left, representative fluorescence images of the sorted Cherry positive cells in (C) after culturing for 1 week. Scale bar, 250 mm. Right, percentages of GFP positive colonies were quantified and shown as the mean percentages of GFP positive colonies ±SD of two biological replicates. (E) Bisulfite sequencing of cells described in (C) . (F) GFP expression of cells with target gRNAs remained off whereas cells with the scrambled gRNA and mock controls remained GFP positive ( Figure 2C ). Furthermore, bisulfite sequencing showed that transduction of dCas9-Dnmt3a/gRNAs resulted in a significant increase of DNA methylation in the Snrpn promoter region but not in the adjacent Gapdh region (Figures 2D and 2E ). Further analysis of the GFP-positive and -negative populations within infected Cherry-positive cells showed a more robust methylation of the Snrpn promoter region in Cherry + ;GFP -cells ( Figure S2G ).
To overcome the possible limitation caused by low co-transduction efficiency of both dCas9-Dnmt3a and gRNA lentiviruses, a Doxycycline-inducible dCas9-Dnmt3a expression cassette was integrated into the Gapdh-Snrpn-GFP mES cell line by using a PiggyBac transposon system ( Figure S2H ). After delivery of the same group of target gRNAs, FACS analysis showed that GFP inactivation efficiency was increased to 25% (Figures 2F and S2I) . Sorted Cherry-positive cells showed loss of GFP expression upon Doxycycline treatment (Figure 2G ) and were robustly methylated in the Snrpn promoter region ( Figure 2H ). We also generated a new construct of dCas9-Dnmt3a-P2A-BFP, which enables isolation of dCas9-Dnmt3a-expressing cells by FACS. $70% of GFP inactivation efficiency was achieved in FACS sorted double-positive cells (BFP + ;Cherry + ) after lentiviral delivery of this construct together with gRNAs ( Figure S2J ).
In summary, our results indicate that the dCas9 fusion constructs described above either efficiently demethylate methylated sequences (dCas9-Tet1) or de novo methylate unmethylated sequences (dCas9-Dnmt3a) in dividing cells when targeted by specific guide RNAs.
Comparison of dCas9-and TALE-Based Methylation Editing
To compare the methylation editing efficacy and effective range by dCas9-Tet1/Dnmt3a with TALE-based methods, we chose two previously reported loci edited by TALE-based method (Bernstein et al., 2015; Maeder et al., 2013) and designed a single gRNA targeting dCas9-Tet1/Dnmt3a to the same site bound by the TALE-Tet1/Dnmt3a. As shown in Figures S3A and S3C , dCas9-Dnmt3a with one single gRNA targeting the p16 locus induced an average of a 25% increase of methylation within a 320-bp region of the p16 promoter, whereas TALE-Dnmt3a only induced a 13% increase within a 650-bp region. Similarly, dCas9-Tet1 with one single gRNA targeting the RHOXF2 locus induced an average of a 28% decrease of methylation within a 150-bp region of the RHOXF2 promoter, whereas TALE-Tet1 only induced a 14% decrease within a 200-bp region ( Figures  S3B and S3C ). These results suggest that the dCas9-Tet1/ Dnmt3a system has higher efficacy and resolution for methylation editing than the TALE-based method.
To evaluate the specificity of dCas9-Tet1/Dnmt3a-mediated methylation editing, we performed a dCas9 chromatin immunoprecipitation sequencing (ChIP-seq) assay and identified nine binding sites in the presence of gRNAs targeting the Dazl-Snrpn region described in Figure S2A and 18 binding sites in the presence of gRNAs targeting CTCF binding sites adjacent to the miR290 locus (see below Figure S6A ). Figure S3D shows that among the identified binding sites for each group of gRNAs, the targeted locus (Dazl-Snrpn or miR290) showed the highest level of binding for dCas9-Tet1/Dnmt3a (Table S1 ). The second and third strongest binding sites for each targeted locus were illustrated in Figure S3E , and bisulfite sequencing analysis of these loci showed only marginal change in methylation level (Figures S3F and S3G) , likely due to the significantly lower binding affinity of dCas9-Dnmt3a/Tet1 at these off-target loci compared to the targeted loci. These results indicate that dCas9-based epigenetic editing can be highly specific.
Targeted Demethylation of BDNF Promoter IV Activates BDNF in Neurons DNA replication-independent active demethylation has been proposed to operate in post-mitotic neurons (Guo et al., 2011; Martinowich et al., 2003) . To test whether active demethylation can be induced in post-mitotic neurons, we applied the dCas9-Tet1 system to study the regulation of the BDNF gene. BDNF expression can be induced by neuronal activity accompanied by demethylation of its promoter IV (Chen et al., 2003; Martinowich et al., 2003) . We designed four gRNAs targeting 11 CpGs in the BDNF promoter IV ( Figure S4A ) to determine whether dCas9-Tet1 can activate BDNF by inducing demethylation of this promoter (Figure 3A) . Mouse cortical neurons were isolated from E17.5 embryos and cultured for 2 days in vitro (DIV2) following a well-established experimental procedure for producing primary neuronal culture (Ebert et al., 2013) . As shown in Figures S4B-S4D, KCl treatment induced BDNF expression in these neurons with no detectable cell proliferation. Neurons at day 3 in culture (DIV3) were infected with lentiviral vectors expressing dCas9-Tet1 with or without the four gRNAs at almost 100% transduction efficiency ( Figure S4E ). At 48 hr post-infection some of the cultures were treated with KCl to induce neuronal activity. As shown in Figures 3B and 3C , dCas9-Tet1/gRNAs induced BDNF expression by about 6-fold, whereas dCas9-Tet1 in the absence of gRNAs showed only a slight induction (less than 2-fold) and a catalytically dead form of Tet1 (dC-dT) showed no induction. Importantly, the same group of dCas9-Tet1/gRNAs did not induce Npas4 expression ( Figure S4F ), another neuronal activity-inducible gene (Lin et al., 2008) . Co-transduction of dCas9-Tet1 with each individual gRNA targeting the BDNF promoter IV showed a 2-to 3-fold induction of BDNF ( Figure S4G ). We performed bisulfite sequencing to examine the methylation state of BDNF promoter IV. As shown in Figures 3D and 3E , dCas9-Tet1/gRNAs significantly reduced methylation in this region in contrast to gRNA negative controls while KCl treatment also induced demethylation of CpGs at positions of À148, À66 and, À19 (relative to transcription start site).
Our results demonstrate that demethylation of the BDNF promoter IV can be induced by dCas9-Tet1/gRNAs and is sufficient to activate BDNF expression. Because post-mitotic neurons were used for these experiments, loss of methylation was likely due to active demethylation. To further support this conclusion, we examined 5-hmC levels in the BDNF promoter IV during the time course of dCas9-Tet1 induced demethylation by Tet-assisted Bisulfite sequencing (TAB-seq) analysis. As shown in Figure S4H , 5-hmC was detected 40 hr post-infection with dCas9-Tet1 and gRNA lentiviruses and diminished after 60 hr. Similarly, 5-hmC was also detected after KCl treatment (Figure S4I ). As the bisulfite sequencing method does not distinguish unmethylated 5-cytosine (5-C) and 5-formlycytosine/5-carboxylcytosin (5-fC/5-caC) generated from 5-hmC, it is possible that some CpGs were 5-fC/5-caC modified after targeting with dCas9-Tet1/gRNA. Nevertheless, inhibition of the base excision repair pathway by treatment with ABT-888 (an inhibitor of PARP) reduced the activation of BDNF by KCl treatment (Figure S4J ), (DIV3) were infected with lentiviruses expressing dC-T with or without gRNAs targeting the BDNF promoter IV or a catalytically dead form of Tet1 (dC-dT) with BDNF gRNAs for 2 days, and then treated with or without KCl (50 mM) for 6 hr before harvesting for RT-qPCR analysis. Bars are mean ±SD of three biological replicates. (C) Representative confocal images for BDNF induction in (B) . Stained in red for MAP2 (top two panels) or Cherry (bottom two panels), green for BDNF, blue for DAPI and gray for dCas9. Scale bar, 50 mm. suggesting that demethylation of BDNF promoter IV contributes to BDNF activation.
To test whether endogenous Tet activity was required to regulate BDNF expression upon neuronal activity stimulation, we treated DIV3 neurons with 2-hydroxygluterate, a competitive inhibitor for a-ketoglutarate-dependent dioxygenases including Tet enzymes (Xu et al., 2011) . As shown in Figure S4K , pharmacological inhibition of Tet enzymatic activity completely abolished the induction of BDNF expression by KCl treatment. Furthermore, mouse primary cortical neurons carrying a Tet1-null mutant showed significantly attenuated activation kinetics of BDNF ( Figure S4L ), supporting a role of endogenous Tet for induction of neuronal activity.
Targeted Demethylation of the MyoD Distal Enhancer Facilitates Myogenic Reprogramming of Fibroblasts
The role of MyoD as a master regulator for muscle development was initially defined by the observations that demethylation of DNA in fibroblasts by 5-Aza (5-Aza-2 0 -deoxycytidine) treatment resulted in activation of MyoD and subsequent myoblast conversion and myotube formation (Constantinides et al., 1977; Davis et al., 1987; Lassar et al., 1986) . Six muscle-specific DMRs have been described within the 50-kb upstream region of MyoD gene (Schultz et al., 2015), and DMR-5 overlaps with a known distal enhancer of MyoD (Brunk et al., 1996) as shown in Figure 4A . To test whether demethylation of DMR-5 would activate MyoD in fibroblasts, we designed four gRNAs targeting this DMR ( Figure S5A ). Coexpression of dCas9-Tet1 with these gRNAs in C3H10T1/2 cells, a sub-clone from mouse embryonic fibroblasts previously used for 5-Aza mediated MyoD activation (Constantinides et al., 1977) , resulted in a moderate induction of MyoD expression (3-fold) as shown in Figure 4B . Combination of dCas9-Tet1/MyoD DMR-5 gRNAs with 5-Aza treatment resulted in a higher induction of MyoD as shown in Figure S5F . Bisulfite sequencing showed a substantial reduction of methylation in the DMR-5 region of sorted infection-positive cells transduced with dCas9-Tet1 and target gRNAs lentiviruses, but not with a catalytically dead Tet1 (dCdT) or a scrambled gRNA ( Figures 4C and 4D ). To investigate whether demethylation of the MyoD distal enhancer region could reprogram fibroblasts into muscle cells, we infected C3H10T1/2 cells with lentiviruses expressing dCas9-Tet1 and gRNAs. The cells were cultured for 14 days and analyzed for MyoD and MHC (Myosin Heavy chain, a myotube specific marker) expression. As shown in Figures 4E and 4F , co-expression of dCas9-Tet1 with gRNAs targeting DMR-5 induced a moderate expression level of MyoD but was not sufficient to induce myotube formation in the absence of 5-Aza treatment.
We then investigated whether targeted demethylation of DMR-5 would synergize with 5-Aza treatment to induce myotube formation (Figure S5B ). To follow the process of myotube formation after 5-Aza treatment, a time-course experiment was performed. Multi-nucleated myotubes (MHC-positive) with heterogeneous sizes began to form 14 days post-treatment, and both MyoD-positive cell ratio and myotube density and size then increased up to day 25 ( Figures S5C-S5E Targeted De Novo Methylation of CTCF Binding Sites Alters CTCF-Mediated Gene Loops CTCF is a highly conserved zinc finger protein that plays a primary role in the global organization of chromatin architecture (Phillips and Corces, 2009) . Transcriptional enhancers normally interact with their target genes through the formation of DNA loops (Gibcus and Dekker, 2013; Gorkin et al., 2014; Kagey et al., 2010) , which typically are constrained within larger CTCF-mediated loops called insulated neighborhoods (Dowen et al., 2014; Ji et al., 2016; Phillips-Cremins et al., 2013) , which, in turn, can form clusters of loops that contribute to topologically associating domains (TADs) (Dixon et al., 2012; Nora et al., 2012) . Deletion of the CTCF loop anchor sites of insulated neighborhoods can cause enhancers to interact inappropriately with genes located outside the loop and thus increase their expression (Dowen et al., 2014) . Interestingly, methylation of the DNA recognition site of CTCF has been reported to block CTCF binding (Bell and Felsenfeld, 2000; Wang et al., 2012) . To study whether methylation of specific CTCF sites could alter CTCFmediated gene loops, we applied the dCas9-Dnmt3a system to target CTCF anchor sites ( Figure 5A ). We designed specific gRNAs ( Figure S6 ) targeting dCas9-Dnmt3a to two CTCF sites to investigate whether de novo methylation would interfere with the looping function of CTCF ( Figures 5B and 5F ). Doxycycline-inducible dCas9-Dnmt3a mES cells ( Figure S2H ) were infected with lentiviruses expressing the gRNAs and transduced cells were FACS sorted for subsequent analysis.
Targeting of dCas9-Dnmt3a to the CTCF binding site bordering the miR290 loop that harbors a super-enhancer ( Figure 5B) induced de novo methylation of CpGs at this site (Figures 5D and 5E) . Gene expression analysis of transduced cells showed a significant elevation of Nlrp12 gene, which is outside of this super-enhancer-containing insulated neighborhood and next to the targeted CTCF site, but did not affect the expression of genes that are located inside the miR290 loop or of genes in other neighboring loops including AU018091 and Myadm ( Figure 5C ). Similarly, targeting of dCas9-Dnmt3a to the CTCF binding site bordering the Pou5f1 gene loop that harbors another superenhancer ( Figure 5F ) induced methylation of CpGs in the CTCF binding sequence (Figures 5H and 5I) and increased the expression of H2Q10, which is located in a neighboring loop and next to the targeted CTCF site but did not affect the expression of the Pou5f1 gene itself or the Tcf19 gene in the other neighboring loop ( Figure 5G ). For either targeted CTCF sites, a catalytically inactive Dnmt3a form (dC-dD) did not induce changes in methylation level or gene expression as did by dC-D (Figures 5C-5E and 5G-5I). These observations are consistent with the results obtained when these CTCF sites were deleted (Dowen et al., 2014) and support the notion that methylation of the CTCF binding site interferes with its insulator function.
To test whether targeted methylations of CTCF binding sites would result in increased interaction frequencies between (legend continued on next page) insulated super-enhancers and activated genes, Chromosome Conformation Capture (3C) assay was performed at these loci. As shown in Figure 6A , the interaction frequency between super-enhancers in the miR290 loop and the newly activated gene (Nlrp12) in the neighboring loop was significantly increased but the interaction between Nlrp12 and Myadm genes remained the same, indicating an open conformation for this targeted CTCF loop. To confirm that the increased interaction frequency was due to blocking CTCF anchoring, we performed a CTCF ChIP assay. Binding of CTCF to the targeted genomic site was significantly reduced in the sample with miR290 target gRNAs as compared to the sample with a scrambled gRNA, gRNAs targeting other CTCF binding sites, or a catalytically inactive dC-dD with miR290 target gRNAs ( Figure 6B ), supporting the notion that DNA methylation blocks CTCF anchoring and thus alters the CTCF loop conformation. A similar set of experiments was performed for the second CTCF loop (Pou5f1 loop) demonstrating increased interaction frequency between the insulated superenhancers and the newly activated gene (H2Q10) and decreased binding of CTCF after targeted methylation of its binding site ( Figures 6C and 6D ). In summary, our results demonstrate that the dCas9-Dnmt3a system can be used to change the methylation state of specific CTCF anchor sites and thus to interfere with the CTCF looping function.
In Vivo Demethylation of an Endogenous Locus for Gene Activation by dCas9-Tet1
To test whether the dCas9-mediated DNA methylation-editing tools could be used to alter methylation in vivo, we utilized a methylation sensitive reporter mouse previously generated ( Figure 7A ; Stelzer et al., 2016) . In these transgenic mice, a methylation sensitive Snrpn-GFP cassette was inserted into the Dlk1-Dio3 locus to report the methylation status of its intergenic-differentially methylated region (IG-DMR). As the IG-DMR of this locus acquires paternal methylation during spermatogenesis, the GFP reporter (IG-DMR GFP/Pat ) is constitutively repressed in heterozygous mice carrying the paternal Snrpn-GFP allele (Stelzer et al., 2016) . As shown above, the GFP reporter in the Dazl locus was activated by targeted promoter demethylation in mES cells (Figure 1 ). To assess whether the Dlk1-Dio3 locus GFP reporter could be activated by dCas9-Tet1 in differentiated cells, we derived adult mouse skin fibroblast cells from the tails of IG-DMR GFP/Pat transgenic mice, which were then transduced by lentiviruses expressing dCas9-Tet1 with Snrpn target gRNAs or a scrambled gRNA or a catalytically dead form of Tet1 (dC-dT) with Snrpn target gRNAs ( Figure 7A ). The results in Figures 7B and 7C reveal GFP reporter activation in about 80% of Cherry (gRNA) positive fibroblasts but only when transduced by both dCas9-Tet1 and Snrpn gRNAs lentiviruses.
FACS analysis of these cells further confirmed this notion (Figures S7A-S7C) .
To investigate whether the DNA methylation status can be modified in vivo, we infected three epidermal sites on the ventral side of an IG-DMR GFP/Pat transgenic mouse with the dCas9-Tet1
and Snrpn gRNAs ( Figure S7D ). Cells were sparsely infected with cherry expression seen only in some of the hair follicles. dCas9-Tet1 with Snrpn gRNAs, but not dCas9-Tet1 with the scrambled gRNA or dC-dT with Snrpn gRNAs, was able to activate GFP reporter expression in about 85% infected skin dermal cells in vivo ( Figures 7H, S7E, and S7F ). In addition, we infected the brain of an IG-DMR GFP/Pat transgenic mouse with lentiviral vectors using a stereotaxic setup and analyzed the effect on targeted DNA methylation in brain slices by confocal microscopy. To eliminate possible inter-individual variability, we injected lentiviral vectors expressing dCas9-Tet1 and Snrpn gRNAs, as well as the two negative control vector combinations into different regions of the same brain ( Figure 7D ). As shown in Figures 7E and 7F , after infection with all three lentiviral combinations, only lentiviral vectors expressing dCas9-Tet1 with Snrpn gRNAs, but not vectors expressing dCas9-Tet1 with sc gRNA or dC-dT with Snrpn gRNAs, activated the GFP reporter with an activation efficiency of about 70% ( Figure 7G ).
DISCUSSION
In this study, we have repurposed the CRISPR/Cas9 system to edit the methylation status of genomic sequences. The catalytically inactive Cas9 protein (dCas9) was fused either to the catalytic domain of Tet1 (dCas9-Tet1) or to Dnmt3a (dCas9-Dnmt3a) to predictably alter the epigenetic state of target sequences. A GFP reporter inserted into the promoter region of the methylated and silenced Dazl gene was demethylated and activated when targeted by dCas9-Tet1, whereas the GFP reporter inserted into the promoter region of the active and unmethylated Gapdh gene was de novo methylated and silenced when targeted by dCas9-Dnmt3a. When the dCas9-Tet1 was targeted to the inactive BDNF promoter IV in post-mitotic neurons, the promoter became demethylated and activated. Importantly, this tool predictably altered the methylation state and activity of regulatory regions: targeted demethylation of the inactive distal enhancer of MyoD activated the gene and facilitated muscle cell transdifferentiation and targeted methylation of CTCF anchor sites inhibited CTCF binding and interfered with its function as an insulator between gene loops. Finally, the editing tools can in vivo alter the methylation state of regulatory sequences as injection of the lentiviral vectors of dCas9-Tet1 with target gRNAs into the dermis or brain of transgenic mice demethylated the methylated Snrpn promoter in the Dlk1-Dio3 imprinted locus and activated the methylation-sensing GFP reporter.
(C-E) Doxycycline-inducible dCas9-Dnmt3a mESCs were infected with lentiviruses expressing a scrambled gRNA or CTCF target-1 gRNAs. Cherry-positive cells were FACS sorted, cultured in the presence of Doxycycline, and then harvested for RT-qPCR analysis in (C), for bisulfite-sequencing analysis in (D) and (E) . Bars represent mean ± SD of three experimental replicates. (F) Schematic representation of CTCF target-2 with super-enhancer and Pou5f1 gene in this loop as in (B) . (G-I) The same set of experiments was performed as described in C-E for CTCF target-2, and cells were harvested for RT-qPCR analysis in (G) and for bisulfite sequencing in (H) and (I) . Bars represent mean ± SD of three experimental replicates. See also Figure S6 .
Dynamic DNA methylation has been proposed to decode neuronal activities (Sweatt, 2013) . For instance, treatment of neurons with KCl has been shown to de-silence promoter IV of BDNF and induce BDNF expression associated with demethylation of some methylated CpGs in this promoter region (Chen et al., 2003; Martinowich et al., 2003) . When the BDNF promoter IV was targeted by dCas9-Tet1, extensive demethylation of methylated CpGs was observed, and BDNF was activated to a similar level as when the cultures were treated with KCl. Because the neurons were post-mitotic, the dCas9-Tet1-mediated demethylation of the promoter sequences was likely the result of active demethylation as has been proposed previously (Wu and Zhang, 2014) . Although it is possible that some CpGs in the BDNF promoter were 5-fC/5-caC modified after targeting with dCas9-Tet1/gRNA, blocking restoration of 5-fC/5-caC into unmethylated cytosine by inhibition of the BER pathway reduced Figure 5C at the miR290 locus. The super-enhancer domain is indicated as a red bar. The targeted CTCF site is highlighted with a box. Arrows indicate the chromosomal positions between which the interaction frequency was assayed. Asterisk indicates the 3C anchor site. ChIP-seq binding profiles (reads per million base pair) for CTCF in black and H3K27Ac (super-enhancer) in red, and methylation track in yellow with DMR in blue are also shown. The interaction frequencies between the indicated chromosomal positions and the 3C anchor sites are displayed as a bar chart (mean ± SD) on the bottom panel. qPCRs were run in duplicates, and values are normalized against the mean interaction frequency in cells with a scrambled gRNA. (p < 0.05 for all three regions; Student's t test; ns, non-significant; NC, negative control.) (B) Anti-CTCF ChIP experiment was performed using cells in (A) followed by quantitative PCR analysis. Bars represent mean ± SD of three experimental replicates. (C) Quantitative Chromosome Conformation Capture (3C) analysis of cells described in Figure 5G at the Pou5f1 locus as in (A) . (D) Anti-CTCF ChIP experiment was performed using cells in (C) followed by quantitative PCR analysis. Bars represent mean ± SD of three experimental replicates.
BDNF expression, suggesting that demethylation of the BDNF promoter IV contributes to the activation of BDNF. Importantly, our results establish a causal relationship between the demethylation of BDNF promoter IV and gene activation. The role of DNA methylation as a barrier between cell lineages is consistent with the previous observation that demethylation of DNA in fibroblasts by treatment with 5-Aza can activate MyoD and mediate myotube formation (Constantinides et al., 1977) . Targeting of dCas9-Tet1 to the methylated distal enhancer of MyoD in fibroblasts induced demethylation of CpGs and resulted in a moderate activation of MyoD but failed to generate myoblasts. However, when dCas9-Tet1/gRNA lentiviral transduction was combined with 5-Aza treatment, a significantly enhanced myoblast and myotube formation was observed as compared to 5-Aza treatment alone. It is possible that demethylation of the additional DMRs in combination with the distal enhancer may be required to induce efficient conversion of fibroblasts to myoblasts. Recent studies of mammalian chromosome structures reveal that chromatin is organized in topologically associating domains and gene loops mediated by chromatin architecture proteins such as Cohesin and CTCF (Dekker and Mirny, 2016) . Emerging data suggest that higher-order chromatin structures confer epigenetic information during development and are frequently altered in cancer (Ji et al., 2016; Narendra et al., 2015) . It has been reported that binding of CTCF is inhibited when its recognition sequence is methylated (Bell and Felsenfeld, 2000; Wang et al., 2012) . Targeting of dCas9-Dnmt3a to two CTCF binding sites induced de novo methylation of CpGs in these sites and interfered with the insulator function of the protein as evidenced by increased interaction frequencies between insulated super-enhancers in the targeted loop and genes in the neighboring loop causing upregulation of these genes. This suggests that the dCas9-Dnmt3a system is a useful tool to manipulate chromatin structure and to assess its functional significance during development and in disease context.
Our results indicate that dCas9 fused to the epigenetic effectors Tet1 and Dnmt3a represents a powerful toolbox to edit DNA methylation of specific genomic sequences. Comparison of these tools with the TALE-based method showed a higher efficacy and resolution for methylation editing, and dCas9 ChIPseq followed by bisulfite sequencing of potential off-target binding loci revealed marginal changes in methylation levels, suggesting that high specificity can be achieved with properly designed gRNAs. During the preparation of our manuscript, Vojta et al. also reported that dCas9 fused with Dnmt3a can be used to methylate two human gene promoters (Vojta et al., 2016) , and Xu et al. and Choudhury et al. reported that dCas9 fused with Tet1 can be used to demethylate gene promoters (Choudhury et al., 2016; Xu et al., 2016) . Therefore, these dCas9-Dnmt3a/Tet1 tools will be useful to gain insight into the functional significance of DNA methylation in diverse biological processes such as gene expression, cell-fate determination, and organization of high-order chromatin structures.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mouse lines and breeding strategies Tet1 mutant mice were previously generated in our lab (Dawlaty et al., 2011) . Tet1 KO mice in the study were maintained in a mixed 129 and C57BL/6 background. To obtain Tet1 KO mice, male and female mice heterozygous for Tet1 were crossed. To obtain wildtype mouse primary cortical neurons, male and female C57BL/6 mice were mated. IG-DMR GFP/Pat methylation reporter mouse line was generated as described (Stelzer et al., 2016) . Male mice with IG-DMR GFP/Pat reporter allele were crossed with C57BL/6 females to generate adult offsprings carrying the paternally transmitted allele for in vivo DNA methylation editing analysis. Mice were handled in accordance with institutional guidelines and approved by the Committee on Animal Care (CAC) and Department of Comparative Medicine (DCM) of Massachusetts Institute of Technology.
Mouse primary cortical neuron culture, EDU labeling, and neural induction Dissociated E17.5 cortical neuron cultures were generated from wild-type or Tet1 KO mouse embryos as described previously (Ebert et al., 2013) . Briefly, E17.5 cortices were dissected in ice-cold 1 X HBSS (GIBCO 14185-052) containing 1 x pen/strep (GIBCO: 15140122), 1 x pyruvate (GIBCO: 11360070) and 30 mM Glucose. Tissues were minced into around 1 mm 3 and dissociated with
Papain neural tissue dissociation system (Worthington Biochemicals) following the manufacturer's instruction. Cells were resuspended in NM5 media (%5 FBS (Hyclone), 2% B27 supplement (GIBCO 17504044), 1 x pen/strep and 1 x glutamax I (GIBCO 35050-061)). 1 3 10 6 cells were plated per well of a 6-well plate coated with poly-D-lysine (PDL, Sigma). On DIV2, cells were treated with 2.5 uM AraC overnight (Sigma C-6645) to eliminate the excessive cell division of mitotic astrocytes and neural progenitor cells.
Cultures were fed at DIV3 with fresh NM5 media and subsequently membrane depolarized with 50 mM KCl or infected with preferred lentivirus. We started the treatment at the very beginning of the in vitro culture so the step of AP5 and TTX (tetrodotoxin) treatment to silence basal activity in the culture before KCl treatment was omitted. For EDU labeling, primary neuronal culture were treated with EDU at a final concentration of 10 uM for 24 hr followed by Click-it EDU labeling procedure according to the manufacturer's instruction (Thermo Fisher Scientific). Cells were fixed for immunohistochemical analysis, lysed in Trizol to extract total RNA for RT-qPCR or lysed to extract DNA for bisulfite sequencing analysis.
METHOD DETAILS
Plasmid design and construction PCR amplified Tet1 catalytic domain from pJFA344C7 (Addgene plasmid: 49236), Tet1 inactive catalytic domain from MLM3739 (Addgene plasmid: 49959), or Dnmt3a from pcDNA3-hDNMT3A (Addgene plasmid: 35521) were cloned in modified pdCas9 plasmid (Addgene plasmid: 44246) with BamHI and EcoRI sites. Then dCas9-NLS-Tet1 or dCas9-NLS-Dnmt3a were PCR amplified and cloned into FUW vector (Addgene plasmid: 14882) with AscI and EcoRI to package lentiviruses. NLS-dCas9-NLS-Tet1 was cloned by inserting annealed oligos (NLS) into FUW-dCas9-NLS-Tet1 with XbaI and AscI. The gRNA expression plasmids were cloned by inserting annealed oligos into modified pgRNA plasmid (Addgene plasmid: 44248) with AarI site. The PiaggyBac-dCas9-Tet1 and -dCas9-Dnmt3a were cloned by ligation of PCR-amplified dCas9-NLS-Tet1 or dCas9-NLS-Dnmt3a from FUW constructs with modified PiggyBac transposon vector (Wilson et al., 2007) with NheI and EcoRI. All constructs were sequenced before transfection. Primer information for gRNA design and construction is listed in Table S2 . Related plasmids have been deposited into Addgene plasmid database. TALE-Dnmt3a construct targeting p16 locus is a gift from Dr. Klaus Kaestner, and TALE-Tet1 targeting RHOXF2 locus is from Addgene (Plasmid #49943). Full-length protein sequences of dCas9-Dnmt3a and dCas9-Tet1CD and their mutants are listed in Table S6 .
Cell culture, lentivirus production, and stable cell line generation Mouse embryonic stem cells (mESCs) were cultured on irradiated mouse embryonic fibroblasts (MEFs) with standard ESCs medium: (500 ml) DMEM supplemented with 10% FBS (Hyclone), 10 ug recombinant leukemia inhibitory factor (LIF), 0.1 mM b-mercaptoethanol (Sigma-Aldrich), penicillin/streptomycin, 1 mM L-glutamine, and 1% nonessential amino acids (all from Invitrogen). C3H10T1/2 cells were cultured in standard DEME medium with 10% FBS. Lentiviruses expressing dCas9-Tet1, dCas9-Dnmt3a, and gRNAs were produced by transfecting HEK293T cells with FUW constructs or pgRNA constructs together with standard packaging vectors (pCMV-dR8.74 and pCMV-VSVG) followed by ultra-centrifugation-based concentration. Virus titer (T) was calculated based on the infection efficiency for 293T cells, where T = (P*N) / (V), T = titer (TU/ul), p = % of infection positive cells according to the fluorescence marker, N = number of cells at the time of transduction, V = total volume of virus used. Note TU stands for transduction unit. To generate stable cell lines with integrated Doxycycline-inducible dCas9-Tet1 or dCas9-Dnmt3a transgenes, PiggyBacdCas9-Tet1 or -dCas9-Dnmt3a construct, with a helper plasmid expressing transposase, were transfected into C3H10T1/2 cell using X-tremeGENE 9 transfection reagent (Roche) or into mESCs cells using Xfect transfection reagent (Clontech), according to the provider's protocol. Stably integrated cells were selected with G418 (400 ug/ml) for 10 days. Adult mouse fibroblasts were derived from tails of IG-DMR GFP/Pat reporter mice. Briefly, $2 cm-long mouse tail was obtained from 3 month old mouse carrying paternally transmitted IG-DMR-Snrpn-GFP methylation reporter, and sterilized by 70% EtOH. $2 mm x 2 mm minced tail pieces were digested with 5 ml of 1mg/ml Collagenase IV at 37 C for 90 min in a 15 ml Falcon tube. 5 ml MEF medium were added into the tube to terminate the digestion. Dissociated cells were extruded through a 40 um cell strainer with gentle grind using a syringe plug. Cells were then collected and cultured for viral infection. Cells were analyzed 3 days post-infection in this study. 4 TU/ul and 1.2 3 10 5 TU/ul respectively. Mice were sacrificed 3 days after infection. The animals were fixed by transcardial perfusion with 4% paraformaldehyde (PFA)/PBS. Fixed skin pads and brain samples were dissected and post fixed with 4% paraformaldehyde (PFA)/PBS overnight at 4 C. The brain samples were sectioned with a vibratome (Leica VT1100) at 150 um thickness and the skin samples were sectioned with a cryostat (Leica) at 10 um thickness followed by immunohistochemical analysis. For vibratome sectioning, tissues were embedded in 3% agarose gel. For cryosectioning, tissues were equilibrated in 30% sucrose/PBS prior to embedding in Optimal Cutting Temperature (OCT) compound.
Immunohistochemistry, microscopy, and image analysis Neurons, HEK293T cells, mouse ES cells and C3H10T1/2 cells were fixed with 4% paraformaldehyde (PFA) for 10 min at room temperature. Cells were permeablized with PBST (1 x PBS solution with 0.1% Triton X-100) before blocking with 10% Normal Donkey Serum (NDS) in PBST. Cells were then incubated with appropriately diluted primary antibodies in PBST with 5% NDS for 1 hr at room temperature or 12 hr at 4 C, washed with PBST for 3 times at room temperature and then incubated with desired secondary antibodies in TBST with 5% NDS and DAPI to counter stain the nuclei. Cells were washed 3 times with PBST before mounted onto slides with Fluoromount G (SouthernBiotech). Immunostaining procedures for tissue sections were previously described (Wu et al., 2014a) . Briefly, sections were permeablized with PBST (1 x PBS solution with 0.5% Triton X-100) for 1 hr at RT before blocking with 10% Normal Donkey Serum (NDS) in PBST. Slices were then incubated with desired primary antibodies in PBST with 5% NDS for 24 hr at 4 C, washed with PBST for 3 times at room temperature and then incubated with secondary antibodies in TBST with 5% NDS and DAPI to counter stain the nuclei. Sections were washed 3 times with PBST before slide mounting. The following antibodies were used in this study: Chicken anti-GFP (1:1000, Aves Labs), Mouse anti-Cas9 (7A9, 1:1000, Active Motif), Rabbit anti-BDNF (1:1000, Abcam), Chicken anti-MAP2 (1:1000, Encor Biotech), Mouse anti-MAP2 (1:1000, Sigma-Aldrich), Mouse anti-Tuj1 (1:1000, Biolegend), Rabbit anti-MyoD (C-20, 1:1000, Santa Cruz Biotechnology), Mouse anti-MHC (MF20, 1:1000, R&D systems). Images were captured on a Zeiss LSM710 confocal microscope and processed with Zen software, ImageJ/Fiji, and Adobe Photoshop. For imaging based quantification, unless otherwise specified, 3-5 representative images were quantified and data were plotted as mean ± SD with Excel or Graphpad.
FACS analysis
To assess the proportion of GFP and/or Cherry positive cells after treatment, the treated cells were dissociated with trypsin and single-cell suspensions were prepared in growth medium subject to a BD FACSAria cell sorter according to the manufacture's protocol at the Whitehead Institute Flow Cytometry Core. Data were analyzed with FlowJo software.
Fibroblast-to-myoblast conversion assay Myoblast conversion assay was described previously (Constantinides et al., 1977) . Briefly, C3H10T1/2 mouse embryonic fibroblast cells were plated as 1 3 10 4 cells per well in 6-well plate, and then infected with lentiviruses expressing dCas9-Tet1 and target gRNAs. 24 hr post infection, cells were treated with vehicle control (HEPES buffer) or 5-Azacytidine (1 uM) for 24 hr, and harvested at different time points for subsequently analysis. DMRs upstream of mouse MyoD gene were defined based on human/mouse genome homology (Schultz et al., 2015) .
Western blot HEK293T cells were transfected with various constructs by X-tremeGENE 9 reagent following manufacturer's protocol. 2-day post transfection, cells were lysed by RIPA buffer with proteinase inhibitor (Invitrogen), and subject to standard immunoblotting analysis. Mouse anti-Cas9 (1:1000, Active Motif) and mouse a-Tubulin (1:1000, Sigma) antibodies were used.
RT-qPCR
Cells were harvested using Trizol followed by Direct-zol (Zymo Research), according to manufacturer's instructions. RNA was converted to cDNA using First-strand cDNA synthesis (Invitrogen SuperScript III). Quantitative PCR reactions were prepared with SYBR Green (Invitrogen), and performed in 7900HT Fast ABI instrument. Primer information for RT-qPCR is listed in Table S3 .
ChIP assay
ChIP experiment was performed as previously described (Dowen et al., 2014) . Briefly, cells were cross-linked by 1% formaldehyde in the medium for 10 min in room temperature, and then quenched by adding 0.125 M Glycine for 5 min. Collected cells were washed with PBS twice, and then re-suspended in 3.5 ml of sonication buffer. Sonication was performed for 10 cycles with 0.5 min pulse on and 1 min rest, and 24 W in ice-water mixture. Then cell lysate was spun down with 14,000 x rpm for 10 min at 4 C. 50 ul of supernatant was saved as input for gDNA. 10 ul of anti-CTCF antibody (EMD Millipore: 07729) or anti-Cas9 antibody (Active Motif) was added and incubate overnight at 4 C. 50 ul protein G dynabeads was added into antibody-cell lysate mixture and incubate overnight at 4 C. Then beads were washed with sonication buffer, sonication buffer with high salt (500 mM NaCl), LiCl wash buffer, and TE buffer. Bound protein-DNA complex was eluted from beads by incubation in a 65 C oven for 15 min, and then reverse cross-linked under 65 C overnight. The bound DNA was purified with QIAGEN QIAquick PCR Purification Kit, and then subject to qPCR analysis or sequencing.
ChIP-seq data analysis Sequencing data was analyzed with a previously reported method . Reads are de-multiplexed and the first 25 bases are mapped to mouse genome (mm10) using STAR (Dobin et al., 2013) , requiring unique mapping allowing one mismatch. Mapped reads are collapsed and the same number of reads (about 15 million) are randomly sampled from each sample to match sequencing depth. Peaks are called using MACS with default settings. For each sample, the other five samples are each used as a control and only peaks called over all five controls are defined as candidate peaks. Candidate peaks are filtered by fold of enrichment over background and the threshold is chosen such that no peaks pass this threshold in the four control samples (input, mock IP, dCas9 alone, and scrambled gRNA). Note that six candidate peaks in input mapped to 45S rRNA and mitochondria DNA are excluded from the analysis. Raw data is available in the following link: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi? token=ktohskmgnhudhud&acc=GSE83890
Bisulfite Conversion, PCR and Sequencing Bisulfite conversion of DNA was established using the EpiTect Bisulfite Kit (QIAGEN) following the manufacturer's instructions. The resulting modified DNA was amplified by first round of nested PCR, following a second round using loci specific PCR primers (Table  S3 ). The first round of nested PCR was done as follows: 94 C for 4 min; 55 C for 2 min; 72 C for 2 min; Repeat steps 1-3 1 X; 94 C for 1 min; 55 C for 2 min; 72 C for 2 min; Repeat steps 5-7 35X; 72 C for 5 min; Hold 12 C. The second round of PCR was as follows: 95 C for 4 min; 94 C for 1 min; 55 C for 2 min; 72 C for 2 min; Repeat steps 2-4 35 X; 72 C for 5 min; Hold 12 C. The resulting amplified products were gel-purified, sub-cloned into a pCR2.1-TOPO-TA cloning vector (Life technologies), and sequenced. Primer information for bisulfite sequencing is listed in Table S4 .
Locus-specific TAB-seq TAB-Seq was performed as described previously (Yu et al., 2012) . Briefly, 1 ug of genomic DNA from treated mouse cortical neuron was glucosylated in a solution containing 50 mM HEPES buffer (pH 8.0), 25 mM MgCl2, 100 ng/ml model DNA, 200 mM UDP-Glc, and 1 mM bGT at 37C for 1 hr. After the reaction, the DNA was column purified. The oxidation reactions were performed in a solution containing 50 mM HEPES buffer (pH 8.0), 100 mM ammonium iron (II) sulfate, 1 mM a-ketoglutarate, 2 mM ascorbic acid, 2.5 mM DTT, 100 mM NaCl, 1.2 mM ATP, 15 ng/ml glucosylated DNA, and 3 mM recombinant mTet1. The reactions were incubated at 37C for 1 hr. After proteinase K treatment, the DNA was column purified and then applied to EpiTect Bisulfite Kit (QIAGEN) following the supplier's instruction. The resulting modified DNA was amplified by first round of nested PCR, following a second round using loci specific PCR primers (Table S3 ). The resulting amplified products were gel-purified, sub-cloned into a pJET cloning vector (Life technologies), and sequenced. Primer information for bisulfite sequencing is listed in Table S4 .
Chromosome Conformation Capture (3C) assay 5 3 10 6 mESCs were fixed with 1% formaldehyde for 20 min at room temperature, and the reaction was quenched by 0.125 M glycine for 5 min at room temperature. Cross-linked cells were collected and washed with 1 ml ice cold PBS. Cell pellet was re-suspended with 550 ml lysis buffer (10 mM Tris-HCl with pH 8.0, 10 mM NaCl, and 0.2% IGEPAL CA630 with proteinase inhibitor), and incubated on ice for 20 min. Cell pellet was then washed twice with 1 3 NEB buffer 2 (NEB, B7002S), then incubated with 50 ìl 0.5% SDS for 10 min at 62 C. After heating, 145 ìl H 2 O and 25 ml 10% Triton X-100 were added into the mixture and incubate for 15 min at 37 C. 25 ml 10 3 NEB buffer 2 and 100 U BglII (NEB, R0144S) were added to digest chromatin over night at 37 C. The digest reaction was inactivated by incubation for 20 min at 62 C. Then 713 ml H2O, 120 ml 10 3 T4 DNA ligase buffer (NEB, B0202), 100 ml 10% Triton X-100, 12 ml 10 mg/ml BSA, and 5 ml T4 DNA ligase (NEB, M0202) were added and incubated for 22 hr at 16 C. The chromatin was reverse cross-linked, and DNA was purified by phenol:chloroform:isoamyl alcohol (Sigma, P3803) extraction. The 3C interactions at the miR290 and Pou5f1 loci ( Figures 6A and 6C) were analyzed by quantitative real-time PCR using custom Taqman probes. The amount of DNA in the qPCR reactions was normalized across 3C libraries using a custom Taqman probe directed against the Actb locus. Primer and probe sequences are listed in Table S5 .
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical parameters including the exact value of n, the definition of center, dispersion, and precision measures (mean ± SEM) and statistical significance are reported in the Figures and the Figure Legends . Data is judged to be statistically significant when p < 0.05 by two-tailed Student's T-Test or 2-way ANOVA, where appropriate.
DATA AND SOFTWARE AVAILABILITY
The accession number for the raw data files for the ChIP-seq analysis is NCBI Gene Expression Omnibus: GSE83890. A) Design of dCas9-effector constructs with nuclear localization signal (NLS) located at different positions, and guide RNA (gRNA) or enhanced guide RNA (E-gRNA) with CMV-driven puro-T2A-Cherry cassette. Ub: human Ubiquitin C promoter. (B) Expression of dCas-NLS-Tet1 and NLS-dCas9-NLS-Tet1 was analyzed by immunoblotting with anti-Cas9 antibody after transfection with these constructs in HEK293T cells for 2 days. a-tubulin was used as a loading control. (C) Comparison of the cellular localization of dCas9-NLS-Tet1 and NLS-dCas9-NLS-Tet1 in HEK293T cells with or without co-expression of a gRNA or E-gNRA targeting the same position in the MyoD locus. In the absence of sgRNAs, dCas9-NLS-Tet1 is predominantly excluded from the nuclear compartment, and NLSdCas9-NLS-Tet1 shows weak nuclear localization in transfected HEK293T cells. Co-expression of either gRNA or E-gRNA induced cytoplasm-to-nucleus translocation of these two proteins. Stained in green for dCas9, red for Cherry and blue for DAPI in the merged images. The red dashed lines in the first two panels indicate the cross section of the images for GFP intensity quantification. Scale bar: 10 um. (D) Quantification of the nuclear-cytoplasmic ratio of dCas9-NLS-Tet1 and NLS-dCas9-NLS-Tet1 in HEK293T cells in the absence or presence of a gRNA, or an E-gNRA in a Box and Whiskers plot. Average dCas9 intensity of cytoplasmic and nuclear domain along a cross-sectional line as illustrated in C was used for the quantification. ''+'' denotes mean value of the 20 data points in each group; the boxes indicate the extreme data points (top and bottom bars), the 25%-75% interval (box), and the median (central line). (E) Quantification of induction index (defined as the nuclear-cytoplasmic ratio with sgRNA normalized to that without sgRNA) for dCas9-NLS-Tet1 and NLSdCas9-NLS-Tet1. gRNA and E-gRNA induced 3.17 and 3.22 folds of nuclear localization for dCas9-NLS-Tet1, and 1.73 and 1.77 folds for NLS-dCas9-NLS-Tet1, respectively. We reasoned that the combination with the highest induction index would result in the best signal-to-noise ratio for targeted DNA methylation editing. 
